Low- and middle-income countries
49 articles
Bridging the Diagnostic Gap: A Rapid, Cost-Effective, and Equitable Hepatitis C Virus RNA Detection Method for Resource-Limited Settings
A study evaluated two loop-mediated isothermal amplification detection methods - hydroxynaphthol blue (HNB, colorimetric) and calcein (fluorescent) - against an in-house TaqMan qPCR assay. More
Evaluating Performance of the Bioline™ HCV Point-Of-Care Test in Ghana
A study assessed the diagnostic performance of the Bioline™ HCV POC test in Ghanaian HCV target populations. More
Long-Acting Therapies Trials Tracker for Hepatitis C, Opioid Use and Overdose Prevention Therapy, and Malaria
Treatment Action Group releases a trials tracker providing a compilation of ongoing and recently completed clinical trials on long-acting therapies for HCV, opioid use and overdose prevention therapy, and malaria in the R&D pipeline. More
TAG and LAT CAB Welcome Indian Patent Office Decision That Could Expand Access to Hepatitis C Treatment
TAG and the LAT CAB celebrate the Indian Patent Office’s decision to NOT grant a patent on the HCV combination treatment glecaprevir/pibrentasvir, aka Mavyret® or Maviret® manufactured by AbbVie. More
